A major international collaboration led by Melbourne researchers has discovered that the world’s most widespread malaria parasite infects humans by hijacking a protein the body cannot live without.
The researchers were then able to successfully develop antibodies that disabled the parasite from carrying out this activity.
The study, led by the Walter and Eliza Hall Institute’s Associate Professor Wai-Hong Tham and Dr Jakub Gruszczyk, found that the deadly malaria parasite Plasmodium vivax (P. vivax) causes infection through latching onto the human transferrin receptor protein, which is crucial for iron delivery into the body’s young red blood cells.
Published today in Science, the discovery has solved a mystery that researchers have been grappling with for decades.
Associate Professor Tham, who is also a HHMI-Wellcome International Research Scholar, said the collective efforts of teams from Australia, New Zealand, Singapore, Thailand, United Kingdom, United States, Brazil and Germany had brought the world closer to a potential effective vaccine against P.vivax malaria.
“P. vivax currently inflicts a huge burden on global health. It is the most common malaria parasite in countries outside of Africa, with more than 16 million clinical cases recorded each year.
“The parasite can lie dormant in the liver for months on end without causing any symptoms, which makes it very sneaky and difficult to treat,” Associate Professor Tham said.
“We now know that P. vivax is hijacking the human transferrin receptor which is essential for transporting iron into the body’s young red blood cells.
“Being able to stop P. vivax from latching onto this receptor and infliltrating the blood is a major breakthrough and important step towards malaria elimination,” she said.
Dr Gruszczyk said once the teams understood how the parasite was gaining entry into the cells, they were able to design antibodies to block the mode of access.
“Using the Australian Synchrotron in Melbourne, we generated a 3D map of the parasite protein which is the mechanism P. vivax uses to latch onto the human transferrin receptor and enter the young red blood cells.
“This map provided an unprecedented view of the parasite protein’s shape, which guided the design of antibodies to block P. vivax from gaining entry into the human cells,” Dr Gruszczyk said.
Associate Professor Tham said they were thrilled to see the antibodies successfully block P. vivax invasion using parasites from both Thailand and Brazil. “We are now looking to include collaborative partners in the Pacific, so we can further test the effectiveness of our antibodies,” she said.
Study collaborator Dr Jonathan Abraham from Harvard University said the results of the new study aligned with a growing body of evidence that could be used to target multiple infectious diseases.
“Transferrin receptor is also co-opted by five viruses that cause Ebola-like diseases in South America. These diseases are known as New World haemorrhagic fevers.
“Our increasing understanding of how several pathogens are taking advantage of transferrin receptor, means we are getting closer to disrupting infection for a number of deadly diseases,” Dr Abraham said.
The Latest on: Malaria parasite
NIH researchers identify sequence leading to release of malaria parasites from red blood cells
on July 11, 2018 at 9:09 am
The vacuole, a compartment inside human red blood cells in which malaria parasites reproduce and develop, takes on a distinct spherical shape just minutes before its membrane ruptures, leading to the ... […]
What is schistosomiasis, what are the symptoms of bilharzia and how is the deadly parasitic disease treated?
on July 11, 2018 at 5:16 am
Schistosomiasis is caused by an infection of schistosome flatworms in the body. The infection occurs when people come into contact with a type of freshwater snail that produces the worms. These worms ... […]
Why some people test positive for malaria after successful anti-malarial treatment
on July 10, 2018 at 7:47 am
The human malaria parasite has developed partial resistance to every drug used to treat it, particularly the first-line treatment, ACT (artemisinin combination therapy). In order to curb the further s... […]
The deadly parasitic worm that’s set to invade Europe – and it lays its eggs INSIDE human organs
on July 10, 2018 at 7:42 am
IT'S the second most deadly parasitic disease - only malaria is more lethal. And schistosomiasis - also known as snail fever - could be set to invade Europe's shores. Schistosome worms penetrate the s... […]
Certain antibodies against a sugar are associated with malaria protection
on July 10, 2018 at 3:36 am
Certain type of antibodies against α-Gal, a carbohydrate expressed by many organisms including the malaria parasite, could protect against malaria, according to a new study led by ISGlobal, an institu... […]
Certain antibodies against a carbohydrate could protect against malaria
on July 10, 2018 at 2:29 am
Certain type of antibodies against α-Gal- a carbohydrate expressed by many organisms including the malaria parasite- could protect against malaria, according to a new study led by ISGlobal, an institu... […]
Atomic imaging exposes how malaria invades our blood cells
on July 9, 2018 at 5:33 pm
vivax, invades our red blood cells. The mosquito-borne malaria parasite is an ancient killer, predating the emergence of humans. It has stalked us our entire history, possibly killing Alexander the Gr... […]
Novel Vaccine Candidates for Malaria: Study
on July 7, 2018 at 4:18 am
The findings of the study are published in Infection and Immunity. Children who have higher levels of antibodies to a specific short amino acid sequence in the malaria parasite, P. falciparum, have mu... […]
Flea medication for people and other new tools to combat malaria
on July 5, 2018 at 11:06 am
They could also protect us from sand flies bearing the tropical disease leishmaniasis. Related Content Malaria parasites taint donor blood in some African countries, study suggests Opting out of vacci... […]
New Blood Test to Measure Antibodies Against Malaria Developed
on July 4, 2018 at 8:09 am
It can assess natural and vaccine-induced responses to malaria and other parasites. A simple, accurate, and reproducible assay to measure antibodies against multiple Plasmodium falciparum proteins (or ... […]
via Google News and Bing News